Effect of prognostic nutritional index on laboratory parameters and survival in metastatic colorectal cancer patients treated with fruquintinib: a retrospective study

Citations Over TimeTop 21% of 2024 papers

Abstract

This study suggests that fuquinitinib can improve the survival of patients with metastatic colorectal cancer. Patients with high levels of PNI have a better prognosis and longer survival time, ensuring the nutritional status of patients can be a help to improve the treatment of fuquinitinib.

Related Papers

• → Survival Analysis: A Self-Learning Text(1997)1,358 cited
• → Survival Analysis: A Self-Learning Text(1997)816 cited
• → Survival Analysis: A Self-Learning Text.(1996)331 cited
• → An Introduction to Survival Analysis(2007)90 cited
• → Prognostic Significance of COX-2 Immunohistochemical Expression in Colorectal Cancer: A Meta-Analysis of the Literature(2013)68 cited